site crawlran 4m ago·24 Jun, 19:59·runs daily 06:00
Click any tile above to filter the table. Click any row to expand and see the full meta, schemas, alt text, H2 counts, links, depth, and per-page tools (View live · Test schema · PageSpeed). Click Edit next to Title or Meta to change the value live.
—
URL / H1
H1
Title
Meta
Canon
OG
Schema
Author
Capsule
Crumbs
In
Words
▸
Growth-hormone-releasing peptides (UK research overview)
First-party research from PeptideClear: the UK Peptide Transparency Index, CoA Trust Index and UK peptide and weight-loss statistics. Not medical advice.
The UK Peptide Transparency Index: how openly UK research-peptide retailers publish certificates of analysis. Editorial transparency data, not medical advice.
UK GLP-1 prescribing tracker: NHS primary-care volumes
Meta description (250 chars)
How much GLP-1 medication the NHS prescribes in England: 393,874 primary-care prescription items in June 2025, 3.95m items over the latest 12 published months. Updated from the NHSBSA English Prescribing Dataset. Information only, not medical advice.
Compare UK peptide retailers, GLP-1 clinics, pharmacies, and collagen brands side by side. Independent editorial head-to-heads on sourcing, pricing, and fit.
Phlo vs Pharmacy2U (UK): which low-touch GLP-1 pharmacy fits
Meta description (155 chars)
UK comparison of Phlo and Pharmacy2U GLP-1 online pharmacies. Pricing, app vs web, NHS compatibility, range, audience fit. Both low-touch, different shape.
Numan vs Voy (UK): which high-touch GLP-1 clinic fits
Meta description (159 chars)
UK comparison of Numan and Voy GLP-1 clinics. Pricing, programme shape, aftercare framing, switch policies, audience fit. Both high-touch. Different strengths.
Numan vs Phlo (UK): high-touch clinic vs low-touch pharmacy
Meta description (155 chars)
UK comparison of Numan (high-touch GLP-1 clinic) and Phlo (low-touch GLP-1 pharmacy). Different products at different price points. Which suits which user.
GHK-Cu vs Matrixyl 3000: UK cosmetic peptide compared
Meta description (156 chars)
UK comparison of GHK-Cu copper peptides and Matrixyl 3000 in cosmetic skincare. Mechanism, evidence base, formulation requirements, what to layer with, and.
UK editorial comparison of CJC-1295 and Sermorelin. Both GHRH analogues. Different amino acid length, different half-lives, different research positioning.
Bare Biology vs Vital Proteins: UK marine collagen compared
Meta description (157 chars)
UK editorial comparison of Bare Biology and Vital Proteins marine collagen. UK independent vs global brand. Dose, kDa, sourcing transparency, price per gram.
Hydrolysed vs native collagen: absorption and dose explained
Meta description (154 chars)
UK editorial comparison of hydrolysed and native collagen forms. Why hydrolysed dominates the supplement market, where native (undenatured Type II) makes.
Juniper vs Voy (UK): which women-focused GLP-1 clinic
Meta description (153 chars)
UK comparison of Juniper and Voy for women. Both have strong women-skewed programmes. Menopause-aware care, aftercare framing, pricing, HRT coordination.
GHK-Cu copper peptide UK: what it is, what concentration
Meta description (155 chars)
UK guide to GHK-Cu copper peptide skincare. What it is, how it works, what concentration matters in UK serums. Boots, Cult Beauty, LookFantastic stockists.
PeptideClear tools: half-life, supply cost, true cost per mg
Meta description (152 chars)
UK research peptide tools. Half-life calculator, 12-month supply cost calculator, and true cost-per-mg calculator. Pure math utilities. No dosing tools.
Peptide reconstitution calculator (UK research use only)
Meta description (158 chars)
UK peptide reconstitution math: mg vial + ml bacteriostatic water + target dose mcg = units on a U-100 insulin syringe. Research use only, not medical advice.
True cost-per-mg calculator: shipping and minimum order included
Meta description (168 chars)
Correct a research peptide sticker price to the true delivered cost per mg. Vial price plus shipping and minimum order quantity, divided by the mg you actually receive.
Cognitive Stack UK: Semax plus Selank research overview
Meta description (155 chars)
UK editorial overview of the Cognitive Stack. Russian-research nootropic pairing of Semax and Selank. Mechanism, regulatory status, UK retailer comparison.
UK editorial guide to compounds discussed for joint recovery: BPC-157, TB-500, and ingestible collagen. Evidence grades, regulatory status, prescriber framing.
UK editorial guide to compounds in cognitive and nootropic research: Semax, Selank, and the wider nootropic landscape. Evidence, regulation, prescriber framing.
Longevity stack UK: Epitalon, MOTS-c, NAD precursors
Meta description (157 chars)
UK editorial guide to longevity-research compounds: Epitalon, MOTS-c, and NAD precursors. Evidence grades, mechanism, regulatory framing, prescriber routing.
Recovery Stack UK: BPC-157 plus TB-500 plus IGF-1 LR3 research overview
Meta description (156 chars)
UK editorial overview of the Recovery Stack. BPC-157 plus TB-500 plus IGF-1 LR3. Preclinical recovery and growth-pathway literature. UK retailer comparison.
Hulk Stack UK: Ipamorelin plus CJC-1295 research overview
Meta description (157 chars)
UK editorial overview of the Hulk Stack (Ipamorelin plus CJC-1295). Components, dual GH-pathway mechanism, UK retailers stocking each compound ranked by CoA.
Wolverine Stack UK: BPC-157 plus TB-500 research overview
Meta description (159 chars)
UK editorial overview of the Wolverine Stack (BPC-157 plus TB-500). Components, preclinical rationale, UK retailers stocking each compound ranked by CoA Trust.
Healing Stack UK: BPC-157, TB-500, KPV research overview
Meta description (154 chars)
UK editorial overview of the Healing Stack. BPC-157 plus TB-500 plus KPV. Tissue repair preclinical literature. UK retailer comparison ranked by CoA tier.
UK editorial overview of the Glow Stack. Cosmetic-peptide blend targeting skin appearance. GHK-Cu, Argireline, palmitoyl peptides. UK retailer comparison.
How PeptideClear rates retailers, clinics, and pharmacies
Title tag (59 chars)
Trust Review: how we vet retailers, clinics, and pharmacies
Meta description (156 chars)
The five-point framework we use to rate UK peptide retailers, GLP-1 clinics, and pharmacies. CoA tiers, source hierarchy, Verified criteria, COI disclosure.
Mounjaro in Stoke-on-Trent: the NHS route and the alternatives
Title tag (55 chars)
Mounjaro in Stoke-on-Trent: NHS route and access (2026)
Meta description (151 chars)
How to access weight-management medication in Stoke-on-Trent: the local NHS route under NICE TA1026 and nationwide private routes. We do not prescribe.
Mounjaro in Newcastle upon Tyne: the NHS route and the alternatives
Title tag (60 chars)
Mounjaro in Newcastle upon Tyne: NHS route and access (2026)
Meta description (156 chars)
How to access weight-management medication in Newcastle upon Tyne: the local NHS route under NICE TA1026 and nationwide private routes. We do not prescribe.
Mounjaro in Brighton and Hove: the NHS route and the alternatives
Title tag (58 chars)
Mounjaro in Brighton and Hove: NHS route and access (2026)
Meta description (154 chars)
How to access weight-management medication in Brighton and Hove: the local NHS route under NICE TA1026 and nationwide private routes. We do not prescribe.
UK peptide manufacturing explained: who actually makes the molecules
Title tag (60 chars)
UK peptide manufacturing: who actually makes these molecules
Meta description (153 chars)
Where UK peptides are synthesised. MHRA-regulated CDMOs, named makers like Almac, Sterling, and Biosynth Pepceuticals, and the named-lab signal on a CoA.
Honest UK answers across our four areas: research peptides, GLP-1 medications, collagen supplements, and cosmetic peptides. Editorial, evidence-led, no product ranking.
What does the published evidence report about weight regain after stopping Mounjaro?
Title tag (74 chars)
Weight regain after stopping Mounjaro: what the evidence reports (UK 2026)
Meta description (300 chars)
Editorial commentary on the published literature. Published trial data and observational cohort analyses report that a substantial proportion of patients regain weight after stopping GLP-1 medications, including tirzepatide. The SURMOUNT-4 trial reported significant weight regain in the cohort that
What does the Mounjaro Patient Information Leaflet say about missed doses?
Title tag (49 chars)
Mounjaro missed dose: what the PIL says (UK 2026)
Meta description (300 chars)
Editorial commentary on the published Patient Information Leaflet. The MHRA-approved PIL for Mounjaro (tirzepatide) contains a missed-dose section describing what the manufacturer recommends if a weekly dose is missed, including a time window after which the missed dose should be skipped. PeptideCle
Where does the authoritative information on Mounjaro side effects live?
Title tag (74 chars)
Mounjaro side effects: where the authoritative information lives (UK 2026)
Meta description (207 chars)
Editorial commentary pointing to the MHRA-approved Patient Information Leaflet and SmPC as the authoritative references for Mounjaro side effects. We do not reproduce a triage runbook or give medical advice.
What does the published guidance say about Mounjaro and contraception?
Title tag (55 chars)
Mounjaro and contraception: what the PIL says (UK 2026)
Meta description (300 chars)
Editorial commentary on the published Patient Information Leaflet and Summary of Product Characteristics. The MHRA-approved PIL for Mounjaro (tirzepatide) notes that tirzepatide slows gastric emptying, which may reduce the absorption of oral medicines including oral contraceptives. The PIL discusses
What does the published guidance say about GLP-1 medications, pregnancy, and contraception?
Title tag (61 chars)
GLP-1 medications and pregnancy: what the SmPC says (UK 2026)
Meta description (300 chars)
Editorial commentary on the published Summaries of Product Characteristics, Patient Information Leaflets, and NHS contraception guidance. The MHRA-approved SmPCs and PILs for tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda) state that these medications are contraindicated in p
Editorial commentary on published NICE guidance. NICE TA1026 sets the framework for NHS tirzepatide (Mounjaro) access in England, phased across cohorts prioritised by clinical need. Cohort 1 (BMI 40+, four or more qualifying comorbidities) has been live since June 2025. Cohort 2 is scheduled for 23
What does the published guidance say about switching between Wegovy and Mounjaro?
Title tag (69 chars)
Switching between Wegovy and Mounjaro: editorial commentary (UK 2026)
Meta description (300 chars)
Editorial commentary on the published Summaries of Product Characteristics and UK prescribing practice. Both Wegovy (semaglutide) and Mounjaro (tirzepatide) are UK prescription-only medicines licensed for weight management within their respective MHRA-approved indications. A switch between the two i
Argireline is the brand name for acetyl hexapeptide-8, a 6-amino-acid cosmetic peptide marketed as a topical line-reduction ingredient. The mechanism...
Can you stack peptides and vitamin C in the same routine?
Title tag (67 chars)
Can you stack peptides and vitamin C in the same routine? (UK 2026)
Meta description (151 chars)
Generally yes, but separate them by time and watch the pH. Copper peptides (GHK-Cu) are destabilised by low-pH L-ascorbic acid vitamin C in the same...
Why does copper peptide packaging matter? (UK 2026)
Meta description (152 chars)
Copper peptide molecules oxidise on prolonged air exposure, particularly in clear jars where light also reaches them. The blue tint of a fresh GHK-Cu...
What is the best time of day to take collagen? (UK 2026)
Meta description (152 chars)
For tendon and connective tissue goals: 60 minutes before exercise, as in the Shaw 2017 protocol (15 g hydrolysed collagen plus 50 mg vitamin C). For...
What is the difference between Type I and Type II collagen?
Title tag (69 chars)
What is the difference between Type I and Type II collagen? (UK 2026)
Meta description (154 chars)
Type I and Type II are different molecules taken at different doses for different goals. Type I is the dominant collagen in skin, hair, nails, tendons,...
Marine or bovine collagen, which should I choose? (UK 2026)
Meta description (153 chars)
Marine collagen is almost entirely Type I, sourced from fish skin and scales, typically the smallest molecular weight (1 to 3 kDa). Bovine collagen is...
Research peptides FAQ (UK): legality, regulation, what HPLC
Meta description (166 chars)
UK FAQ on research peptides. Legal status, MHRA enforcement, what HPLC purity proves, why no human RCTs, what "research use only" means. Encyclopedia framing.
Are research peptides on the WADA prohibited list?
Title tag (60 chars)
Are research peptides on the WADA prohibited list? (UK 2026)
Meta description (300 chars)
Yes. Most research peptides commonly sold in the UK appear on the World Anti-Doping Agency (WADA) prohibited list under section S2 (peptide hormones, growth factors and related substances). BPC-157, TB-500, Ipamorelin, GHRP-2/6, CJC-1295, Tesamorelin, Sermorelin, and IGF-1 are all prohibited at all
What does 99% HPLC purity actually mean? (UK 2026)
Meta description (300 chars)
A 99 percent HPLC purity claim means that when a sample of the peptide is run through high-performance liquid chromatography, at least 99 percent of the detectable peptide content is the named molecule. It is the standard purity benchmark for UK research peptide retailers. HPLC does not prove biolog
How are research peptides stored and handled? (UK 2026)
Meta description (300 chars)
Research peptides ship lyophilised (freeze-dried) as a white powder in sealed glass vials. Lyophilised peptides are reasonably stable at room temperature for short transit, and substantially more stable when refrigerated (2 to 8°C, 6 to 12 months) or frozen (minus 18°C or colder, 12 to 24 months). R
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protein originally identified in human gastric juice. The Sikiric research group at the University of Zagreb has published most of the preclinical literature on it since 2003, primarily on tendon healing, gut
What does "research use only" actually mean? (UK 2026)
Meta description (300 chars)
"Research use only, not for human or animal consumption" is the regulatory framing under which research peptides without UK MHRA marketing authorisation are sold in the UK. The wording positions the product outside the medicines tier of the Human Medicines Regulations 2012. It is not a posit
Most research peptides commonly sold in the UK (BPC-157, TB-500, MOTS-c, Ipamorelin, Sermorelin, Tesamorelin, CJC-1295) are not controlled under the Misuse of Drugs Act 1971 and not scheduled under the Psychoactive Substances Act 2016. They have no UK MHRA marketing authorisation as medicines but ar
Encyclopedia: peptides, GLP-1, collagen, UK regulators
Meta description (154 chars)
Plain-English UK encyclopedia entries on peptides, collagen, GLP-1 medications, NHS rollout, body composition measurement, and the regulators behind them.
Peptide therapy for weight loss: what people usually mean
Meta description (152 chars)
Peptide therapy for weight loss usually means a licensed GLP-1 medicine. The research peptides some clinics market have no human trials for weight loss.
How UK GLP-1 patients dispose of used pen needles safely: sharps bins, council collection, pharmacy returns, and what a good supplier ships with the pen.
NHS GLP-1 access explained: phased rollout under NICE TA1026
Meta description (157 chars)
NHS England is rolling Mounjaro out for weight management in phased cohorts by BMI and comorbidity count, over up to 12 years. Cohort 1 live since June 2025.
A wearable sensor that reports interstitial glucose every 1 to 5 minutes for 10 to 14 days. Originally for diabetes; now used in longevity and metabolic health.
Specialist Weight Management Service (SWMS) explained
Meta description (153 chars)
NHS tier-3 service providing multi-disciplinary support for severe obesity. The commissioning route through which NHS Mounjaro is delivered in most ICBs.
Peptide therapy for women is not one defined treatment. It can mean a licensed GLP-1 medicine, cosmetic peptides or collagen, each in a different UK category.
Sleep apnoea as a GLP-1 eligibility comorbidity explained
Meta description (160 chars)
Obstructive sleep apnoea (OSA) counts toward NICE TA1026 comorbidity eligibility for NHS Mounjaro. The diagnostic threshold, the link to obesity, and why GLP-1.
Peptide therapy vs hormone therapy (TRT, HRT): a UK guide
Meta description (157 chars)
Peptide therapy and hormone therapy (TRT, HRT) sit in different UK categories: TRT and HRT are MHRA-licensed; peptide therapy products are research use only.
kDa is the unit of molecular weight on collagen labels. 2 to 3 kDa marine collagen absorbs better than 5 to 6 kDa bovine, because smaller peptides cross the.
HbA1c explained: the 3-month average glucose marker
Meta description (154 chars)
HbA1c (glycated haemoglobin) reflects average blood glucose over the previous 8 to 12 weeks. The standard NHS marker for diabetes diagnosis, control, and.
Semaglutide and liraglutide: the UK licensing and regulatory record
Title tag (52 chars)
Semaglutide and liraglutide: the UK licensing record
Meta description (154 chars)
Editorial commentary on the UK regulatory record for semaglutide and liraglutide: MHRA licensing and NICE appraisals TA875 and TA664. We do not prescribe.
How does tirzepatide (Mounjaro) work? Plain-English guide
Meta description (159 chars)
Tirzepatide is a once-weekly dual GIP and GLP-1 receptor agonist. How it works, what the trials show (up to around 20% weight loss), and its UK safety framing.
VO2 max explained: the cardiorespiratory fitness measure
Meta description (153 chars)
VO2 max is the maximum rate of oxygen consumption during exhaustive exercise. The single best predictor of all-cause mortality after adjusting for other.
A calm editorial on what GLP-1 weight-loss medication does and does not do: real trial results, what gets oversold, regain after stopping, cost, and stigma.
Peptide therapy vs GLP-1: how they differ in the UK
Meta description (151 chars)
Peptide therapy and GLP-1 medications sit in different UK categories: GLP-1s are MHRA-licensed; peptides sold as peptide therapy are research use only.
RMR is the energy your body uses at rest. Falls during weight loss, including on GLP-1. How RMR is measured, why it matters for maintenance after goal weight.
"Research use only" framing explained (UK research peptides)
Meta description (153 chars)
The regulatory wording under which research peptides are sold in the UK. What it does and does not authorise, why the framing matters, and where it sits.
Compounded vs licensed GLP-1: the UK position explained
Meta description (165 chars)
Compounded GLP-1 (custom-mixed semaglutide or tirzepatide) is common in the US but is not part of routine authorised UK supply (unlicensed "Specials" aside).
GLP-1 medications and hair loss: what the evidence shows
Meta description (156 chars)
Hair loss is a reported adverse effect of GLP-1 weight-loss medication, most often telogen effluvium linked to rapid weight loss. What the literature shows.
Peptide therapy for muscle growth: the UK regulatory picture
Meta description (160 chars)
Peptides marketed for muscle growth (ipamorelin, CJC-1295, sermorelin) are sold research use only, with no human trials for these uses; several are WADA-listed.
Peptide therapy for skin: cosmetic peptides explained
Meta description (159 chars)
Peptide therapy for skin usually means topical cosmetic peptides such as copper peptides (GHK-Cu) and Matrixyl, sold as general-sale skincare, not injectables.
GLP-1 medications often reduce alcohol cravings and tolerance. The neuroscience, the published observational data, and what UK prescribers typically advise.
ApoB testing explained: the cardiovascular risk biomarker
Meta description (155 chars)
Apolipoprotein B is a more accurate cardiovascular risk biomarker than LDL cholesterol. Why UK longevity clinics include it in baseline bloods, and how it.
Peptide therapy is a marketing term used by private clinics, most often for injectable research peptides with no UK marketing authorisation for human use.
Sarcopenia and GLP-1: why muscle loss matters during rapid
Meta description (159 chars)
Sarcopenia is age-related muscle loss. GLP-1 medications accelerate weight loss including lean mass. The mechanism, the clinical context, and why preservation.
The Merrifield 1963 method for building peptides one amino acid at a time on an insoluble resin. Why peptide cost scales non-linearly with amino acid length.
Longevity supplements UK: NAD+, NMN and longevity peptides
Meta description (191 chars)
Editorial UK hub for the longevity supplement landscape: NAD+ and its precursors NMN and NR, plus longevity-marketed peptides. Food-supplement framing, preclinical evidence, no health claims.
Perimenopause and GLP-1: weight gain, HRT interactions
Meta description (156 chars)
UK guide to GLP-1 medication during perimenopause. Why menopause weight is different. HRT interactions and what the current evidence does and does not show.
The full methodology PeptideClear uses to rank UK longevity clinics. Bloods panel depth, imaging, body composition, intervention loop, evidence-base alignment.
Methodology: how we rank UK cosmetic peptide products
Meta description (153 chars)
The full methodology PeptideClear uses to rank cosmetic peptide serums, creams and treatments. INCI position, declared concentration, base compatibility.
Methodology: how we rank UK GLP-1 clinics and pharmacies
Meta description (153 chars)
The full methodology PeptideClear uses to rank GLP-1 clinics and online pharmacies. GPhC registration, prescriber model, pricing transparency, switching.
Research peptides UK: encyclopedia and retailer comparison
Meta description (160 chars)
UK guide to research peptides. BPC-157, MOTS-c, ipamorelin and others. Encyclopedia framing only. UK retailer comparison: my-peptides, Pure Peptides UK, Direct.
Ipamorelin (UK): Novo Nordisk history, why pharmaceutical
Meta description (155 chars)
UK encyclopedia entry for ipamorelin. Originally developed by Novo Nordisk as a growth-hormone secretagogue. Phase II discontinued for postoperative ileus.
Semax is a synthetic ACTH (4-10) analog registered in Russia for stroke recovery. UK regulatory status, evidence quality, honest framing. Research use only.
CJC-1295 (UK): GHRH analogue, with and without DAC
Meta description (151 chars)
UK encyclopedia entry for CJC-1295. Long-acting GHRH analogue with optional Drug Affinity Complex (DAC) modification. UK regulatory framing. No dosing.
Independent UK comparison of the next-generation obesity pipeline: retatrutide, CagriSema, survodutide. Mechanism, trial stage, and UK regulatory status side by side. All in clinical trials, none licensed by the MHRA. Editorial only, no dosing.
Survodutide (UK): GLP-1/glucagon dual-agonist under investigation
Title tag (57 chars)
Survodutide (UK): GLP-1/glucagon dual-agonist (BI 456906)
Meta description (195 chars)
Survodutide is a GLP-1/glucagon dual-agonist by Boehringer Ingelheim and Zealand Pharma, studied in obesity and metabolic liver disease (MASH). Phase III ongoing. Not licensed by MHRA. No dosing.
Mazdutide (UK): GLP-1 GCG dual agonist research overview
Meta description (159 chars)
UK encyclopedia entry for Mazdutide. Dual GLP-1 and glucagon receptor agonist. Innovent Biologics clinical development. Phase 3 in China for weight management.
Sermorelin (UK): GHRH analogue with withdrawn FDA history
Meta description (153 chars)
Sermorelin is a 29-amino-acid GHRH analogue. Formerly FDA-approved as Geref (1990-2008) for paediatric GH deficiency, since withdrawn. Research use only.
Selank (UK): Russian clinical data, regulatory status
Meta description (153 chars)
Selank is a synthetic Tuftsin analog registered in Russia. UK regulatory status, evidence quality, honest framing of the Russian data. Research use only.
TB-500 (UK): what it is, animal evidence, regulatory status
Meta description (156 chars)
UK encyclopedia entry for TB-500. Synthetic fragment of thymosin beta-4. Tissue repair animal data, no human RCTs. UK regulatory framing. Research use only.
Cagrilintide is a long-acting amylin analogue by Novo Nordisk, studied with semaglutide as CagriSema. Phase III REDEFINE trials ongoing. Not licensed by MHRA. No dosing.
CagriSema (UK): cagrilintide plus semaglutide combination under investigation
Title tag (57 chars)
CagriSema (UK): cagrilintide plus semaglutide combination
Meta description (185 chars)
CagriSema is the Novo Nordisk fixed-dose combination of cagrilintide (amylin analogue) and semaglutide 2.4mg (GLP-1). Phase III REDEFINE trials ongoing. Not licensed by MHRA. No dosing.
Kisspeptin-10 (UK): Imperial College research, status
Meta description (152 chars)
Kisspeptin-10 is a 10-amino-acid KISS1 fragment studied at Imperial College London. UK regulatory status and honest evidence framing. Research use only.
Peptide therapy UK: what it is, what the evidence says
Meta description (151 chars)
Peptide therapy in the UK explained: cosmetic, research and prescription peptides, the legal position, and what the evidence does and does not support.
5-Amino-1MQ (UK): NNMT inhibitor, preclinical only
Meta description (182 chars)
5-Amino-1MQ is a small-molecule NNMT inhibitor studied in preclinical animal models of obesity. It is not a peptide and has no human trials or approval. Research use only. No dosing.
Where to buy peptides UK: peptide retailers compared
Meta description (157 chars)
Where to buy peptides in the UK, compared editorially: my-peptides, Pure Peptides UK, Direct Sarms and more. CoA Trust Index scoring and what to check first.
Cerebrolysin (UK): mixed clinical evidence, status
Meta description (159 chars)
Cerebrolysin is a porcine brain-derived neuropeptide preparation used in parts of Europe. Eastern European history, Western RCT findings, UK status. No dosing.
Thymosin alpha-1 (UK): immune-modulator peptide research overview
Meta description (157 chars)
UK encyclopedia entry for Thymosin alpha-1. 28-residue immune-modulating peptide. Licensed in several jurisdictions (Italy, China) for hepatitis B and other.
AOD-9604 is a synthetic 16-amino-acid fragment of human growth hormone. Pharmaceutical history, evidence quality, UK regulatory framing. Research use only.
Melanotan (UK): MHRA enforcement and consumer warning
Meta description (155 chars)
Melanotan I and II are synthetic alpha-MSH analogues, subject to active MHRA enforcement and consumer safety warnings. Melanotan I is licensed as Scenesse.
Epitalon (UK): pineal peptide bioregulator, what is known
Meta description (158 chars)
Epitalon (epithalon) is a tetrapeptide bioregulator from the Khavinson group. Telomerase research, pineal-gland focus, longevity claims. UK research use only.
MOTS-c (UK): mitochondrial peptide, longevity literature
Meta description (153 chars)
UK encyclopedia entry for MOTS-c. Mitochondrial-derived peptide. Late-life intervention data in mice (Nature Communications 2021). UK regulatory framing.
DSIP (UK): older EEG sleep evidence, regulatory status
Meta description (157 chars)
DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide from older Russian and German EEG sleep research. Contested mechanism. UK regulatory framing. No dosing.
Tesamorelin (UK): GHRH analogue (EGRIFTA), no licence
Meta description (160 chars)
Tesamorelin is a GHRH analogue with a current FDA-approved indication (EGRIFTA for HIV-associated lipodystrophy). No UK or EMA authorisation. Research use only.
A complete A-Z index of every guide, comparison, evidence record, retailer review and tool on PeptideClear, grouped by topic. Editorial information, not medical advice.
Tirzepatide (Mounjaro) in the UK: dispensing landscape
Title tag (54 chars)
Tirzepatide (Mounjaro) in the UK: regulatory landscape
Meta description (160 chars)
Editorial commentary on the UK regulatory landscape for tirzepatide (Mounjaro): MHRA authorisation, NICE TA1026, NHS access phasing, and 2026 dispensing routes.
Melanotan-1 is on the MHRA list of unlicensed medicines with known safety concerns. UK retailers stocking it are listed for completeness, but PeptideClear does.
Where to buy Epitalon in the UK (research use only)
Meta description (158 chars)
Epitalon is a Russian-research tetrapeptide developed by Vladimir Khavinson. UK retailers stock it under research-use-only framing. Counterfeit risk elevated.
UK retailers stocking MOTS-c research peptide in 2026. my-peptides, Pure Peptides UK, Direct Sarms compared. Research use only, not for human consumption.
Editorial commentary on the UK regulatory status of tesamorelin: no UK authorisation, narrow private-prescription use for HIV-associated lipodystrophy.
Where to buy GHK-Cu copper peptides in the UK (2026)
Meta description (156 chars)
UK retailers stocking GHK-Cu copper peptide skincare in 2026. Cult Beauty, Boots, LookFantastic, Beauty Pie, Space NK compared. Top serums by INCI position.
Shropshire, Telford and Wrekin NHS GLP-1 access (2026): rollout and routes
Meta description (174 chars)
NHS Mounjaro rollout for Shropshire, Telford and Wrekin ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Hertfordshire and West Essex NHS GLP-1 access (2026): rollout and routes
Meta description (172 chars)
NHS Mounjaro rollout for Hertfordshire and West Essex ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
South West London NHS GLP-1 access (2026): rollout and routes
Meta description (161 chars)
NHS Mounjaro rollout for South West London ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Somerset NHS GLP-1 access (2026): rollout and routes
Meta description (152 chars)
NHS Mounjaro rollout for Somerset ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Cornwall and the Isles of Scilly: NHS GLP-1 access
Title tag (76 chars)
Cornwall and the Isles of Scilly NHS GLP-1 access (2026): rollout and routes
Meta description (176 chars)
NHS Mounjaro rollout for Cornwall and the Isles of Scilly ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Hampshire and Isle of Wight NHS GLP-1 access (2026): rollout and routes
Meta description (171 chars)
NHS Mounjaro rollout for Hampshire and Isle of Wight ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Surrey Heartlands NHS GLP-1 access (2026): rollout and routes
Meta description (161 chars)
NHS Mounjaro rollout for Surrey Heartlands ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
West Yorkshire NHS GLP-1 access (2026): rollout and routes
Meta description (158 chars)
NHS Mounjaro rollout for West Yorkshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
North West London NHS GLP-1 access (2026): rollout and routes
Meta description (161 chars)
NHS Mounjaro rollout for North West London ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Leicester, Leicestershire and Rutland: NHS GLP-1 access
Title tag (81 chars)
Leicester, Leicestershire and Rutland NHS GLP-1 access (2026): rollout and routes
Meta description (181 chars)
NHS Mounjaro rollout for Leicester, Leicestershire and Rutland ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
North East and North Cumbria NHS GLP-1 access (2026): rollout and routes
Meta description (172 chars)
NHS Mounjaro rollout for North East and North Cumbria ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Bedfordshire, Luton and Milton Keynes: NHS GLP-1 access
Title tag (81 chars)
Bedfordshire, Luton and Milton Keynes NHS GLP-1 access (2026): rollout and routes
Meta description (181 chars)
NHS Mounjaro rollout for Bedfordshire, Luton and Milton Keynes ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Cambridgeshire and Peterborough NHS GLP-1 access (2026): rollout and routes
Meta description (175 chars)
NHS Mounjaro rollout for Cambridgeshire and Peterborough ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Lincolnshire NHS GLP-1 access (2026): rollout and routes
Meta description (156 chars)
NHS Mounjaro rollout for Lincolnshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Birmingham and Solihull NHS GLP-1 access (2026): rollout and routes
Meta description (167 chars)
NHS Mounjaro rollout for Birmingham and Solihull ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Nottingham and Nottinghamshire NHS GLP-1 access (2026): rollout and routes
Meta description (174 chars)
NHS Mounjaro rollout for Nottingham and Nottinghamshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Black Country NHS GLP-1 access (2026): rollout and routes
Meta description (157 chars)
NHS Mounjaro rollout for Black Country ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Lancashire and South Cumbria NHS GLP-1 access (2026): rollout and routes
Meta description (172 chars)
NHS Mounjaro rollout for Lancashire and South Cumbria ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Northamptonshire NHS GLP-1 access (2026): rollout and routes
Meta description (160 chars)
NHS Mounjaro rollout for Northamptonshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Coventry and Warwickshire NHS GLP-1 access (2026): rollout and routes
Meta description (169 chars)
NHS Mounjaro rollout for Coventry and Warwickshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Derby and Derbyshire NHS GLP-1 access (2026): rollout and routes
Meta description (164 chars)
NHS Mounjaro rollout for Derby and Derbyshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Buckinghamshire, Oxfordshire and Berkshire West: NHS GLP-1 access
Title tag (91 chars)
Buckinghamshire, Oxfordshire and Berkshire West NHS GLP-1 access (2026): rollout and routes
Meta description (191 chars)
NHS Mounjaro rollout for Buckinghamshire, Oxfordshire and Berkshire West ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Humber and North Yorkshire NHS GLP-1 access (2026): rollout and routes
Meta description (170 chars)
NHS Mounjaro rollout for Humber and North Yorkshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Bristol, North Somerset and South Gloucestershire: NHS GLP-1 access
Title tag (93 chars)
Bristol, North Somerset and South Gloucestershire NHS GLP-1 access (2026): rollout and routes
Meta description (193 chars)
NHS Mounjaro rollout for Bristol, North Somerset and South Gloucestershire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Frimley NHS GLP-1 access (2026): rollout and routes
Meta description (151 chars)
NHS Mounjaro rollout for Frimley ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Staffordshire and Stoke-on-Trent: NHS GLP-1 access
Title tag (76 chars)
Staffordshire and Stoke-on-Trent NHS GLP-1 access (2026): rollout and routes
Meta description (176 chars)
NHS Mounjaro rollout for Staffordshire and Stoke-on-Trent ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
North East London NHS GLP-1 access (2026): rollout and routes
Meta description (161 chars)
NHS Mounjaro rollout for North East London ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
North Central London NHS GLP-1 access (2026): rollout and routes
Meta description (164 chars)
NHS Mounjaro rollout for North Central London ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Suffolk and North East Essex NHS GLP-1 access (2026): rollout and routes
Meta description (172 chars)
NHS Mounjaro rollout for Suffolk and North East Essex ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
South East London NHS GLP-1 access (2026): rollout and routes
Meta description (161 chars)
NHS Mounjaro rollout for South East London ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Herefordshire and Worcestershire: NHS GLP-1 access
Title tag (76 chars)
Herefordshire and Worcestershire NHS GLP-1 access (2026): rollout and routes
Meta description (176 chars)
NHS Mounjaro rollout for Herefordshire and Worcestershire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Gloucestershire NHS GLP-1 access (2026): rollout and routes
Meta description (159 chars)
NHS Mounjaro rollout for Gloucestershire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Norfolk and Waveney NHS GLP-1 access (2026): rollout and routes
Meta description (163 chars)
NHS Mounjaro rollout for Norfolk and Waveney ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Bath, North East Somerset, Swindon and Wiltshire: NHS GLP-1 access
Title tag (92 chars)
Bath, North East Somerset, Swindon and Wiltshire NHS GLP-1 access (2026): rollout and routes
Meta description (192 chars)
NHS Mounjaro rollout for Bath, North East Somerset, Swindon and Wiltshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Kent and Medway NHS GLP-1 access (2026): rollout and routes
Meta description (159 chars)
NHS Mounjaro rollout for Kent and Medway ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Mid and South Essex NHS GLP-1 access (2026): rollout and routes
Meta description (163 chars)
NHS Mounjaro rollout for Mid and South Essex ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
South Yorkshire NHS GLP-1 access (2026): rollout and routes
Meta description (159 chars)
NHS Mounjaro rollout for South Yorkshire ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Greater Manchester NHS GLP-1 access (2026): rollout and routes
Meta description (162 chars)
NHS Mounjaro rollout for Greater Manchester ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
Cheshire and Merseyside NHS GLP-1 access (2026): rollout and routes
Meta description (167 chars)
NHS Mounjaro rollout for Cheshire and Merseyside ICB under NICE TA1026. Cohort 1 live; Cohort 2 from 23 June 2026. Specialist referral routes and private alternatives.
UK regulatory framework for peptides. Live tracker.
Title tag (50 chars)
UK regulatory framework for peptides: live tracker
Meta description (157 chars)
Plain-English UK regulatory hub for peptides, collagen and GLP-1 medicines. MHRA, FDA, WADA, EMA and ASA positions in one place, with a live updates tracker.
BPC-157 UK regulatory status: MoDA, PSA, MHRA, WADA
Meta description (151 chars)
UK legal status of BPC-157. Misuse of Drugs Act, Psychoactive Substances Act, MHRA marketing authorisation, WADA Prohibited List position, ASA framing.
Best UK Tesamorelin retailers (2026): HPLC purity, CoA
Meta description (154 chars)
UK editorial comparison of where to buy Tesamorelin research peptide in 2026. Six UK retailers compared. Research use only. No UK marketing authorisation.
Best UK collagen brands 2026: marine, bovine, vegan compared
Meta description (155 chars)
UK editorial list of the best collagen supplements 2026. Ranked on type, source, dose per serving, kDa molecular weight, third-party testing, and cost per.
Best UK BPC-157 retailers (2026): HPLC purity, CoA
Meta description (159 chars)
UK editorial comparison of where to buy BPC-157 research peptide in 2026. Six UK retailers compared on HPLC purity, Certificate of Analysis, delivery, payment.
Best UK Ipamorelin retailers (2026): HPLC purity, CoA
Meta description (153 chars)
UK editorial comparison of where to buy Ipamorelin research peptide in 2026. Six UK retailers compared on HPLC purity, Certificate of Analysis, delivery.
Best UK marine collagen (2026): dose, kDa, source, price
Meta description (152 chars)
UK editorial list of the 8 best marine collagen supplements in 2026. Ranked on dose per serving, kDa molecular weight, source transparency, third-party.
Best UK copper peptide creams and moisturisers (2026)
Meta description (155 chars)
UK editorial list of copper peptide creams and moisturisers (as distinct from serums). Ranked on INCI position, supporting actives, base compatibility and.
How NHS Mounjaro and Wegovy access works in each UK nation. England Cohort 1/2/3, Scotland BMI 30 specialist-only, Wales TA1026 timing, Northern Ireland 2026.
About PeptideClear: independent UK peptide intelligence
Meta description (159 chars)
Independent UK peptide intelligence. We grade evidence, not prescribe. Editorial comparison of GLP-1 medications, research and cosmetic peptides, and collagen.
Free books from PeptideClear UK. Plain-English commentary on the UK peptide market and its regulation. Read on Kindle, Google Play Books, or download free.
Why Peptides Are Having a Moment in the UK: Free Book by Oliver Mackman
Meta description (204 chars)
A plain-English look at the rise of peptides in the UK: the market context, the regulatory framework (MHRA, ASA, NHS access), and how product quality and seller trust vary. Commentary, not medical advice.
PeptideClear blog: peptides, longevity and GLP-1 in the UK
Meta description (154 chars)
Editorial posts from PeptideClear on UK supplements, longevity compounds (NAD+, NMN, NR), peptides and GLP-1 routes. Evidence framing, no clinical advice.
Where NMN regulation actually landed in the UK after the 2022 to 2025 back-and-forth: legal to sell as a food supplement, a positive EFSA safety opinion, and not yet formally authorised as an EU novel food.
Best NAD+ supplement UK: what to look for on a label
Title tag (52 chars)
Best NAD+ supplement UK: what to look for on a label
Meta description (159 chars)
Editorial checklist for choosing an NAD+ supplement in the UK: precursor type, third-party testing and UK food-supplement claims rules. No product endorsement.
There is no single best IV drip. This guide maps the UK drip categories to the goals people search for, and is honest about where the evidence is weak.
What NAD+ is, why longevity clinics market it, and how the UK routes (IV, injection, oral supplement, NMN and NR precursors) actually differ on regulation and evidence.
What NMN costs per month in the UK, why the per-capsule milligram count is the figure that matters, and how supplement pricing compares with the injection and IV NAD+ routes.
What nicotinamide riboside (NR) is, how it differs from NMN as a NAD+ precursor, and why NR has the more settled UK regulatory and retail history of the two.
The difference between NAD+ and NMN for UK readers. Why most supplements use the NMN precursor rather than NAD+ itself, and how their regulatory status differs.
IV NAD+ in the UK: where it is offered and what to ask
Title tag (54 chars)
IV NAD+ in the UK: where it is offered and what to ask
Meta description (159 chars)
How IV NAD+ works in the UK, where it is offered, what a session involves, and the regulatory and evidence questions to ask before booking. No clinical claims.
How to assess IV NAD+ clinics in London. The registration, compounding and evidence questions that matter, and why we do not publish a fixed clinic ranking.
Supermarket collagen UK: what is on the shelf and what to check
Title tag (63 chars)
Supermarket collagen UK: what is on the shelf and what to check
Meta description (159 chars)
An honest look at the collagen you can buy in UK supermarkets and high-street chains: the formats, what the label should tell you, and where the evidence sits.
What published human trials note on NMN tolerability, why the food-supplement framing matters, and why an absence of reported problems in short studies is not the same as long-term safety.
NMN supplement vs IV NAD+: cost, evidence and route
Title tag (51 chars)
NMN supplement vs IV NAD+: cost, evidence and route
Meta description (158 chars)
How an oral NMN food supplement compares with an IV NAD+ drip at a UK clinic on cost, regulation and evidence, and why the two routes are not interchangeable.
What NAD+ costs in the UK across IV drips, injections and oral supplements. How the price ladder works and why routes are not comparable on price alone.
What ranges published NMN trials have used, why this is not a dosing instruction, and why dose questions for a food supplement belong with a healthcare professional rather than a marketing page.
How to read an NMN supplement label in the UK: per-capsule milligram count, purity claims, batch testing language and the regulatory wording that signals a food supplement rather than a medicine.
Myers cocktail IV in the UK: what the formula looks like
Title tag (56 chars)
Myers cocktail IV in the UK: what the formula looks like
Meta description (151 chars)
The history of the Myers cocktail, what the UK clinic versions typically contain, how it is regulated, and what the evidence base actually consists of.
Oral NAD+, NMN and NR explained for UK readers. Why intact NAD+ is poorly absorbed, what the precursor options are, and what to check on a supplement label.
Why London has the densest UK IV drip market, the chains and independents operating there, what to check before booking, and an honest read on the evidence.
NMN versus NR as NAD+ precursors in the UK: how the two molecules relate, what the human evidence actually shows, and why the choice matters less than the marketing on either side implies.
Nicotinamide riboside (NR) vs nicotinamide mononucleotide (NMN) for UK readers. How the two NAD+ precursors differ on conversion, evidence and regulatory history.
What glutathione is, why clinics deliver it intravenously, how UK regulation treats it, and why the skin-whitening marketing in particular is not supported.
Peptide safety, UK regulation, and reporting side effects
Title tag (57 chars)
Peptide safety, UK regulation, and reporting side effects
Meta description (165 chars)
How UK peptide categories are regulated. What "research peptide" means versus a licensed therapeutic. MHRA, Misuse of Drugs Act, Psychoactive Substances Act.
GLP-1 cost and access in the UK: what you pay (2026)
Meta description (157 chars)
Neutral editorial guide to UK GLP-1 weight-loss medication: the NHS route and eligibility first, then what drives private cost across clinics and pharmacies.
GLP-1 weight-loss medication: UK cost and supply routes
Title tag (55 chars)
GLP-1 weight-loss medication: UK cost and supply routes
Meta description (151 chars)
The regulated UK routes that supply GLP-1 weight-management medication in 2026: NHS, private clinic and pharmacy. Editorial; we do not list POM prices.
Editorial pages translated for Polish, Romanian, and Lithuanian readers in the UK. Same research-use-only standard in every language. Not clinical advice.
Cel mai bun colagen pentru românce în UK: comparație între cultura colagenului lichid din România și branduri UK ca Bare Biology, Skinade și opțiuni Holland & Barrett.
Comentariu editorial în limba română despre cadrele reglementare MHRA și ANMDM pentru tirzepatidă (Mounjaro) și avertismentele ANMDM despre produse falsificate.
PeptideClear Videos: UK peptide evidence explained
Meta description (152 chars)
UK peptide video explainers on BPC-157, TB-500, GHK-Cu, GLP-1 medications, MHRA status, and UK retailers. Editorial commentary only. Not medical advice.
Boots Online Doctor: UK GLP-1 provider profile (2026)
Meta description (158 chars)
Editorial profile of Boots Online Doctor as a UK GLP-1 weight-management route. Regulation, what is included, pricing basis and our take. We do not prescribe.
Superdrug Online Doctor: UK GLP-1 provider profile (2026)
Meta description (162 chars)
Editorial profile of Superdrug Online Doctor as a UK GLP-1 weight-management route. Regulation, what is included, pricing basis and our take. We do not prescribe.
Morrisons Clinic: UK GLP-1 provider profile (2026)
Meta description (155 chars)
Editorial profile of Morrisons Clinic as a UK GLP-1 weight-management route. Regulation, what is included, pricing basis and our take. We do not prescribe.
Asda Online Doctor: UK GLP-1 provider profile (2026)
Meta description (157 chars)
Editorial profile of Asda Online Doctor as a UK GLP-1 weight-management route. Regulation, what is included, pricing basis and our take. We do not prescribe.
SimplyMeds Online: UK GLP-1 provider profile (2026)
Meta description (156 chars)
Editorial profile of SimplyMeds Online as a UK GLP-1 weight-management route. Regulation, what is included, pricing basis and our take. We do not prescribe.
AI instructions for PeptideClear (ChatGPT, Claude, Gemini)
Meta description (154 chars)
How AI assistants should describe and cite PeptideClear: an independent UK editorial hub for peptides. Not a pharmacy, clinic or retailer; we do not sell.
Plain-English UK how-to guides for peptides and GLP-1: choosing a clinic, choosing a research-peptide retailer, and what goes into a reconstitution kit. Editorial only.
How to choose a UK GLP-1 clinic in 2026: 7-point checklist
Meta description (151 chars)
Editorial checklist for UK GLP-1 weight-loss clinics: GPhC and GMC registration, consultation type, refund policy, aftercare, and pricing transparency.
Choosing a UK research peptide retailer: 7-point checklist
Meta description (157 chars)
Editorial checklist for UK research peptide retailers: Companies House status, per-batch CoA, named lab, HPLC and mass spec, endotoxin testing, UK warehouse.
UK reconstitution kit for research peptides: what is actually needed
Title tag (59 chars)
UK reconstitution kit for research peptides: what is needed
Meta description (155 chars)
What goes into a UK research-peptide reconstitution kit: bacteriostatic water, insulin syringes, alcohol swabs, sharps disposal. Editorial only, no dosing.
How PeptideClear researches, sources, fact-checks, and signs off content. NICE, MHRA, NHS guidance. Single editorial byline (Oliver Mackman) for non-clinical.
Free UK editorial calculators and reference tools: collagen dose by goal, and published protein-intake guidance on GLP-1. Evidence-based, not individual clinical advice.
Protein on GLP-1: published-guidance reference math
Title tag (56 chars)
Protein on GLP-1: published guidance math (UK editorial)
Meta description (152 chars)
Editorial reference on published protein-intake guidance during GLP-1 weight loss. ESPEN, PROT-AGE, SURMOUNT-1 DXA data. Not individual clinical advice.
Weight Management: editorial coverage on PeptideClear
Meta description (158 chars)
Editorial index for weight management. UK GLP-1 access routes: clinics, pharmacies, NHS access, and aftercare. Editorial only. Prescriber decides suitability.
Joint Recovery: editorial coverage on PeptideClear
Meta description (158 chars)
Editorial index for joint health. Covers BPC-157, TB-500, Type II collagen, and glucosamine-adjacent compounds. Preclinical summaries only. No medical advice.
Menopausal Health: editorial coverage on PeptideClear
Meta description (155 chars)
Editorial index for menopausal health. Covers perimenopause and GLP-1, PCOS, women-focused clinic routes, and collagen for menopausal skin. Editorial only.
Ipamorelin: UK research-tier pillar on the cleanest ghrelin mimetic
Title tag (67 chars)
Ipamorelin: UK research-tier pillar on the cleanest ghrelin mimetic
Meta description (184 chars)
PeptideClear editorial pillar on Ipamorelin. Pentapeptide GHSR agonist. Preclinical literature, comparison with GHRP-2, GHRP-6, Hexarelin, UK retailers and CoA tier. Research use only.
TB-500 (UK): what the Thymosin Beta-4 fragment is, what the preclinical literature shows, and where UK researchers source it
Title tag (124 chars)
TB-500 (UK): what the Thymosin Beta-4 fragment is, what the preclinical literature shows, and where UK researchers source it
Meta description (299 chars)
UK editorial pillar on TB-500, the synthetic 17-residue fragment of Thymosin Beta-4. Molecular structure, animal-model evidence (wound, cardiac, neuro, hair), human-trial gaps, MHRA and WADA status, UK retailer landscape, and the Wolverine stack. Research use only, no dosing, no therapeutic claims.
NHS GLP-1 Rollout Tracker: Which ICBs Are Commissioning Mounjaro and Wegovy in 2026
Title tag (83 chars)
NHS GLP-1 Rollout Tracker: Which ICBs Are Commissioning Mounjaro and Wegovy in 2026
Meta description (200 chars)
An editorial map of where the NHS rollout of GLP-1 weight management medication stands across the 42 English Integrated Care Boards, plus the separate pathways in Wales, Scotland and Northern Ireland.
NHS access to GLP-1 weight management medications: the patient pathway
Title tag (70 chars)
NHS access to GLP-1 weight management medications: the patient pathway
Meta description (237 chars)
An editorial guide to NHS access for GLP-1 weight management medications in 2026. NICE TA1026, Tier-3 referrals, Integrated Care Board commissioning, realistic wait times, and the private alternative. Your GP decides eligibility, not us.
Body Recomposition: The UK 2026 Editorial Guide to Lean-Mass Preservation on GLP-1 Medication and the Peptide-Research Lane
Title tag (123 chars)
Body Recomposition: The UK 2026 Editorial Guide to Lean-Mass Preservation on GLP-1 Medication and the Peptide-Research Lane
Meta description (255 chars)
An editorial UK long-form on body recomposition in 2026: what the GLP-1 lean-mass literature actually shows, the protein-threshold consensus, resistance-training trial framing, and the research-use-only peptide lane that intersects with this conversation.
GLP-1 Cost and Supply in the UK: The Full 12-Month Budget Guide
Title tag (63 chars)
GLP-1 Cost and Supply in the UK: The Full 12-Month Budget Guide
Meta description (198 chars)
A complete UK breakdown of GLP-1 weight management costs across NHS, private clinic and pharmacy-direct routes. 12-month budget projections, supply considerations and what changes the cost equation.
GLP-1 face: the cosmetic side of rapid weight loss, and what the UK industry is doing about it
Title tag (94 chars)
GLP-1 face: the cosmetic side of rapid weight loss, and what the UK industry is doing about it
Meta description (242 chars)
An editorial long-form on facial volume loss from GLP-1 medications. What is happening anatomically, what UK dermatology and aesthetic medicine practitioners are observing, and where peptide research-tier topical ingredients sit alongside it.
GHK-Cu (Copper Tripeptide-1): the UK editorial guide
Title tag (52 chars)
GHK-Cu (Copper Tripeptide-1): the UK editorial guide
Meta description (269 chars)
A 3000-word UK editorial pillar on GHK-Cu (Copper Tripeptide-1): molecular structure, age-related plasma decline, preclinical literature, the topical cosmetic vs injectable research lane split, UK regulatory framing, sourcing, stacks and outstanding research questions.
UK Longevity Clinics: The 2026 Editorial Guide for Adults Considering Preventative Health
Title tag (89 chars)
UK Longevity Clinics: The 2026 Editorial Guide for Adults Considering Preventative Health
Meta description (253 chars)
A 2026 editorial walk-through of the UK longevity clinic landscape. Hooke, Echelon Health, Reliant Healthcare, Human Longevity (UK arm), Bupa Health Clinics and Nuffield Health compared on what they actually do, what they cost, and where the value sits.
How 22 UK peptide retailers handle Certificates of Analysis
Title tag (35 chars)
UK Peptide Retailer CoA Trust Index
Meta description (158 chars)
Editorial comparison of how every UK research peptide retailer handles Certificates of Analysis. Per-batch publishing, third-party lab partner, gating method.
Boots UK weight management and peptides: routes explained
Meta description (155 chars)
Editorial overview of Boots UK weight-management and peptide routes. Boots Online Doctor, Modern Chemistry, Boots Bioscience, peptide supplements at Boots.
How PeptideClear UK is built to be clear and easy to read and use: search, a full site index, plain English, and keyboard and screen-reader support. We aim to meet WCAG 2.2 AA.
PeptideClear Data API: UK Sellers and COA Verification
Meta description (159 chars)
Read-only public API and MCP server for UK peptide seller data: corporate identity, regulatory status, and CoA verification. REST, OpenAPI 3.1, MCP. CC BY 4.0.
Which cookies PeptideClear sets, what they do, and how to control them. GA4 analytics only, consent-mode-gated. No advertising cookies. No third-party tracking.
UK retailer reviews: peptide and GLP-1 clinics, pharmacies
Meta description (154 chars)
Editorial reviews of every UK clinic, pharmacy and research peptide supplier we link to. Numan, Voy, Manual, Juniper, Phlo, Pharmacy2U, my-peptides, Pure.
Boots Online Doctor review (UK): GLP-1 pharmacy (low-touch)
Meta description (165 chars)
UK editorial review of Boots Online Doctor. Boots online doctor service with weight-loss GLP-1 prescribing alongside the high-street brand. Last reviewed 2026-05-10.
Peptide Labs UK review (UK): Research peptide retailer
Meta description (300 chars)
UK editorial review of Peptide Labs UK. Anti-counterfeit-framed UK research peptide retailer leaning hard on Fat Loss as primary nav category (Tirzepatide, Retatrutide, Mazdutide) alongside the broader catalogue. Above 99 percent HPLC and mass-spec verified purity claim. CoA gated by email request.
UK Peptides review (UK): Research peptide retailer
Meta description (300 chars)
UK editorial review of UK Peptides. 14 years trading from Middlesbrough. The deepest classic-peptide plus Russian-bioregulator catalogue in the UK (Bronchogen, Cartalax, Pinealon, Thymalin, Vilon, Crystagen). Open volume-tier pricing on every PDP with rotating monthly site-wide promo. Publishes a co
Chroma Peptides review (UK): Research peptide retailer
Meta description (186 chars)
UK editorial review of Chroma Peptides. UK research-peptide retailer with per-batch HPLC and independent CoAs and explicit RUO framing across a broad catalogue. Last reviewed 2026-06-03.
Correxiko review (UK): Collagen and skin-health brand
Meta description (218 chars)
UK editorial review of Correxiko. UK collagen and skin-health brand with 75+ SKUs across collagen powders, capsules, bundles, and LED light therapy. Subscription model with bundle discounting. Last reviewed 2026-05-21.
UK editorial review of Phlo. Digital pharmacy with rapid online prescriber consult and same-day delivery in central London. UK-wide tracked dispatch for others. Last reviewed 2026-05-10.
Asda Online Doctor review (UK): GLP-1 pharmacy (low-touch)
Meta description (166 chars)
UK editorial review of Asda Online Doctor. Asda online doctor service with weight-loss GLP-1 prescribing. Supermarket pharmacy distribution. Last reviewed 2026-05-10.
Peptides UK review (UK): Research peptide retailer
Meta description (300 chars)
UK editorial review of Peptides UK. Long-trading UK research peptide retailer (2012). Heavy on classic compounds (BPC-157, TB-500, GHK-Cu, CJC-1295, Ipamorelin, MOTS-c). No GLP-1, no cosmetic line. CoA gated via on-site contact form (request lab report per product). Reconstitution calculator on-site
UK editorial review of OP Labs. Established London research-peptide supplier (formerly Oxford Peptides, RFR Global Ltd) with >=99% HPLC batch COAs and strict RUO framing. Last reviewed 2026-06-03.
Imperial Peptides review (UK): Research peptide retailer
Meta description (225 chars)
UK editorial review of Imperial Peptides. UK research peptide retailer with third-party HPLC plus transparent batch documentation. Plays the credibility lane alongside Pure Peptides UK and Tide Labs. Last reviewed 2026-05-18.
my-peptides review (UK): Research peptide retailer
Meta description (194 chars)
UK editorial review of my-peptides. UK research peptide retailer with HPLC-verified purity claims and CoAs included on orders. Operates under research-use-only framing. Last reviewed 2026-05-10.
UK editorial review of Peptagenix. UK research peptide retailer (Peptagenix UK Ltd, October 2024). Lead category is GLP-1 / Semaglutide. Inline reconstitution dose calculator on homepage. Mail-forwarding Covent Garden address. Athlete-facing framing alongside scientists and labs. Last reviewed 2026-
XL Peptides review (UK): Research peptide retailer
Meta description (300 chars)
UK editorial review of XL Peptides. Nottingham-based research peptide retailer (Bio Research Ltd, since 2024). Bundles and stacks are the hero SKU (Wolverine BPC-157 + TB-500, Tesamorelin + Ipamorelin 3:1, KLOW, Glow). Janoshik third-party CoAs published per batch with QR-code verification. 10-vial
UK editorial review of Tide Labs. UK research peptide retailer leaning on UKAS-verified HPLC as the sole-in-UK trust claim. Narrower catalogue than UKPeptides or Pure Peptides UK but the lab-verification angle is the loudest in the segment. Last reviewed 2026-05-18.
UK editorial review of Voy. Programme-style weight management clinic with strong emphasis on aftercare and maintenance. Was Second Nature historically. Last reviewed 2026-05-10.
Bluewell Peptides review (UK): Research peptide retailer
Meta description (179 chars)
UK editorial review of Bluewell Peptides. UK CoA-verified research-peptide supplier trading since 2022 with >=99.1% HPLC claims and a Trustpilot profile. Last reviewed 2026-06-03.
UK editorial review of Simply Meds. UK online pharmacy with broad weight-loss stocking and routine pharmacy-direct pricing on Mounjaro and Wegovy. Last reviewed 2026-05-10.
Thoroughbred Labs review (UK): Research peptide retailer
Meta description (196 chars)
UK editorial review of Thoroughbred Labs. Established UK research-peptide retailer (since 2022) with HPLC >=99%, a CoA page, clear RUO framing and a registered UK entity. Last reviewed 2026-06-03.
UK editorial review of BIOLAB Shop. UK arm of Polish operator biolabshop.pl. Broader than peptides: peptides, SARMs, nootropics, supplements, skincare across 400+ products. Dedicated /peptides-calculator/ tool page. SHOPONLINEB LTD UK shell (2025) over the Polish parent. ProtonMail-only contact. Las
Rainbow Labs review (UK): Private blood test clinic
Meta description (234 chars)
UK editorial review of Rainbow Labs. London-based private blood test clinic with same-day results. Relevant to PeptideClear readers for GLP-1 bloods, hormone monitoring, and pre-prescription baseline testing. Last reviewed 2026-05-21.
CK Peptides review (UK): Research peptide retailer
Meta description (177 chars)
UK editorial review of CK Peptides. London research-peptide retailer with 99%+ HPLC (Janoshik), third-party CoAs, RUO framing and a Trustpilot profile. Last reviewed 2026-06-03.
Life Extension Europe review (UK): Longevity and research-grade supplements
Meta description (282 chars)
UK editorial review of Life Extension Europe. European arm of Life Extension Foundation. Longevity-focused supplements including NAD+ precursors, peptide-adjacent compounds, collagen, vitamins, and clinical-grade nutraceuticals. 40+ year operating history. Last reviewed 2026-05-21.
Anglo Peptides review (UK): Research peptide retailer
Meta description (199 chars)
UK editorial review of Anglo Peptides. Established London research-peptide retailer (Anglo-Peptides Ltd) with HPLC/MS testing, RUO framing and a strong Trustpilot footprint. Last reviewed 2026-06-03.
UK editorial review of Vital Proteins (UK). US-origin collagen brand with broad UK distribution. Wide product range, mainstream pricing. Last reviewed 2026-05-10.
UK editorial review of Pharmacy2U. One of the largest UK online pharmacies, with NHS infrastructure and full GLP-1 stocking. Lower-priced ongoing scripts than clinics. Last reviewed 2026-05-10.
Direct Peptides UK review (UK): Research peptide retailer (US parent, UK subdomain)
Meta description (300 chars)
UK editorial review of Direct Peptides UK. UK-localised subdomain of US-headquartered Direct Peptides (trademark held by Aspire Labs, Texas). Broadest format coverage in the UK segment: lyophilised vials, pre-mixed pens, nasal-spray stacks, capsules, topical cosmetic peptides. 8 years trading (since
BioPlex Peptides review (UK): Research peptide retailer (peptides + SARMs)
Meta description (300 chars)
UK editorial review of BioPlex Peptides. UK research peptide retailer + SARMs + Peptide Sets (dual-research blends). Founded (claimed) 2012, but trading entity Prime-Physique Ltd was incorporated August 2025. Bristol University biochemistry founders named (Charles Baron, Harry Watts). Weekly rotatin
UK editorial review of Bare Biology. UK collagen brand with marine-sourced peptides and a clean ingredient deck. Strong on women-targeted skin and joint dosing. Last reviewed 2026-05-10.
Pure Peptides UK review (UK): Research peptide retailer
Meta description (300 chars)
UK editorial review of Pure Peptides UK. Long-established UK research peptide supplier. 12 years trading, 15,000+ customers. Operates a public CoA subdomain (coa.purepeptidesuk.com) with downloadable per-batch certificates linked from every PDP. Dual-tier purity (Standard vs Premium with endotoxin L
Dr Peptides review (UK): Research peptide retailer
Meta description (300 chars)
UK editorial review of Dr Peptides. Family-run Newcastle research peptide retailer (Rian, Victoria, Leah Redman). Owner-fronted WhatsApp on every page. CoAs photographed into the product gallery (COA in image) rather than gated. Heavy on named-stack bundles (Wolverine, Hulk, Ultimate Bundle). Crisp
UK editorial review of Maxx Labs. UK research-peptide retailer (trading name of I.H Distributions Ltd, London) with RUO framing and COA/MSDS availability. Last reviewed 2026-06-03.
Nootropic peptides UK: Semax, Selank, Cerebrolysin research
Meta description (153 chars)
UK editorial overview of peptides studied for cognition and anxiety. Semax, Selank, Cerebrolysin. Russian research lineage, mechanism class, UK research.